Improving Laboratory Workflows

Agilent Technologies has introduced a technology designed to help scientists achieve the reproducible results they need to develop effective biopharmaceuticals. It’s line of Advance Bio SEC columns represent an advance in size-exclusion chromatography, a key technology used to quantify aggregation in biotherapeutics such as monoclonal antibodies.

Quantifying aggregation is a vital factor in developing and producing safe, effective biologics. The columns deliver higher resolution for more accurate quantitation as well as higher sensitivity to quantitate aggregates, even at low levels.